Literature DB >> 3950547

Purification and characterization of a membrane protein (gp45-70) that is a cofactor for cleavage of C3b and C4b.

T Seya, J R Turner, J P Atkinson.   

Abstract

Based on preliminary evidence indicating that a cell-associated protein of U937 (a human monocyte-like cell line) possessed cofactor activity and was not the C3b/C4b receptor, we sought to further characterize this protein. A sequential four-column purification procedure was devised that includes C3(H2O) affinity chromatography to isolate in reasonable yields and purity a cell-associated protein of U937 and several other human cell lines. Based on its pattern and Mr on SDS-PAGE, acidic pI, and ligand specificity, it is identical to a recently described C3(H2O) or C3b-binding membrane glycoprotein of human PBL and cell lines; having no presently identified function, it was termed gp45-70. After purifying this protein, we determined its functional capabilities and compared them to those of the other complement proteins with regulatory activity directed at components comprising the C3 convertases. This protein was the most efficient (50 times that of H) yet-described cofactor for the I-mediated first cleavage of C3b. It also was a cofactor for the first cleavage of C4b, but was not as efficient as C4bp. The second cleavage of C3b and C4b was not efficiently mediated. It had no ability to accelerate decay in the classical or alternative pathway C3 convertases. Based on this unique activity profile and ability to be surface labeled, we have renamed this molecule membrane cofactor protein (MCP). We suggest that this protein plays a major role in preventing autologous complement activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950547      PMCID: PMC2188078          DOI: 10.1084/jem.163.4.837

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  30 in total

1.  Purification and characterization of a macromolecular weight cofactor for C3b-inactivator, C4bC3bINA-cofactor, of human plasma.

Authors:  S Nagasawa; R M Stroud
Journal:  Mol Immunol       Date:  1980-11       Impact factor: 4.407

2.  Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b.

Authors:  R Dixit; R Schneider; S K Law; A Kulczycki; J P Atkinson
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

3.  A fluorometric method for determination of C3b inactivator.

Authors:  T Seya; S Nagasawa
Journal:  Clin Chim Acta       Date:  1982-03-12       Impact factor: 3.786

4.  Improved cell surface radioiodination of macrophages.

Authors:  A Kulczycki; V Krause; C C Killion; J P Atkinson
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

5.  The biochemistry of complement.

Authors:  R R Porter; K B Reid
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

6.  Isolation of a biologically active macrophage receptor for the third component of complement.

Authors:  R J Schneider; A Kulczycki; S K Law; J P Atkinson
Journal:  Nature       Date:  1981-04-30       Impact factor: 49.962

7.  Limited proteolysis of the third component of human complement, C3, by heat treatment.

Authors:  T Seya; S Nagasawa
Journal:  J Biochem       Date:  1981-02       Impact factor: 3.387

8.  Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.

Authors:  S Nagasawa; C Ichihara; R M Stroud
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

9.  Complement receptor is an inhibitor of the complement cascade.

Authors:  K Iida; V Nussenzweig
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

10.  The role of C4-binding protein and beta 1H in proteolysis of C4b and C3b.

Authors:  T Fujita; V Nussenzweig
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  120 in total

1.  Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE).

Authors:  M Kawano; T Seya; I Koni; H Mabuchi
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

2.  Identification and characterization of a silencer regulatory element in the 3'-flanking region of the murine CD46 gene.

Authors:  M Nomura; A Tsujimura; N A Begum; M Matsumoto; H Wabiko; K Toyoshima; T Seya
Journal:  Biochem J       Date:  2000-10-15       Impact factor: 3.857

3.  Membrane attack complex of complement and 20 kDa homologous restriction factor (CD59) in myocardial infarction.

Authors:  T Tada; H Okada; N Okada; H Tateyama; H Suzuki; Y Takahashi; T Eimoto
Journal:  Virchows Arch       Date:  1997-04       Impact factor: 4.064

4.  Expression and localization of proteins of the complement system in human skin.

Authors:  N Dovezenski; R Billetta; I Gigli
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

5.  Strong associations between RFLP and protein polymorphisms for CD46.

Authors:  A N Wilton; R W Johnstone; I F McKenzie; D F Purcell
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

6.  CD55 expression patterns on intestinal neuronal tissue are divergent from the brain.

Authors:  K A Gelderman; H J M A A Zijlmans; M J Vonk; A Gorter
Journal:  Gut       Date:  2004-04       Impact factor: 23.059

7.  Analysis of binding sites on complement factor I using artificial N-linked glycosylation.

Authors:  Jose I Sanchez-Gallego; Tom W L Groeneveld; Stefanie Krentz; Sara C Nilsson; Bruno O Villoutreix; Anna M Blom
Journal:  J Biol Chem       Date:  2012-03-05       Impact factor: 5.157

8.  Transcriptional modulation of the human complement factor I gene in Hep G2 cells by protein kinase C activation.

Authors:  J Minta; M Fung
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

9.  Tubulointerstitial injury induced in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement.

Authors:  A Nomura; K Nishikawa; Y Yuzawa; H Okada; N Okada; B P Morgan; S J Piddlesden; M Nadai; T Hasegawa; S Matsuo
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

10.  Extraocular muscle susceptibility to myasthenia gravis: unique immunological environment?

Authors:  Jindrich Soltys; Bendi Gong; Henry J Kaminski; Yuefang Zhou; Linda L Kusner
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.